Literature DB >> 21632551

Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen.

Yoshio Yamauchi1, Keiko Furukawa, Kazunori Hamamura, Koichi Furukawa.   

Abstract

The lipogenic phenotype is a metabolic hallmark of cancer cells. Sterol regulatory element-binding proteins (SREBP) are key transcriptional factors to regulate biosynthesis of cholesterol and fatty acids. It has been poorly understood how the lipogenic phenotype in cancer cells is regulated and how it augments their malignant properties. Here we describe roles of the melanoma antigen ganglioside GD3 and phosphatidylinositol 3-kinase (PI3K)-Akt-mTOR complex 1 (mTORC1) signaling in the regulation of SREBP activity, cholesterol biosynthesis, and the integrity of lipid rafts in human melanoma cells. GD3 expression induced the activation of both SREBP-1 and SREBP-2. Consequently, HMG-CoA reductase expression and cholesterol biosynthesis increased. The activation of the SREBP pathway was independent of the oncogenic BRAF mutation. On the other hand, it was regulated by PI3K-Akt-mTORC1 signaling in human melanoma cells. Disruption of the signaling pathway resulted in the reduction of cholesterol in lipid rafts. Inhibition of the SREBP pathway attenuated Akt activation in lipid rafts and suppressed the growth of human melanoma cells in vitro and in vivo. These results suggest that PI3K-Akt-mTORC1 signaling is important for the integrity of lipid rafts by regulating SREBP activation and subsequent cholesterogenesis. We thus propose a positive feedback circuit in which PI3K-Akt-mTORC1-SREBP signaling boosts Akt signaling in human melanoma cells expressing GD3. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21632551     DOI: 10.1158/0008-5472.CAN-10-4108

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

Review 1.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

Review 2.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

Review 3.  The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease.

Authors:  Yue Zhao; Tian-Yu Wu; Meng-Fei Zhao; Chao-Jun Li
Journal:  J Biol Chem       Date:  2020-03-05       Impact factor: 5.157

Review 4.  SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology.

Authors:  Hitoshi Shimano; Ryuichiro Sato
Journal:  Nat Rev Endocrinol       Date:  2017-08-29       Impact factor: 43.330

5.  6-Ketocholestanol suppresses lipid accumulation by decreasing FASN gene expression through SREBP-dependent regulation in HepG2 cells.

Authors:  Bungo Shirouchi; Shuhei Yanagi; Chinami Okawa; Maiko Koga; Masao Sato
Journal:  Cytotechnology       Date:  2020-01-13       Impact factor: 2.058

6.  Deficiency in the Lipid Exporter ABCA1 Impairs Retrograde Sterol Movement and Disrupts Sterol Sensing at the Endoplasmic Reticulum.

Authors:  Yoshio Yamauchi; Noriyuki Iwamoto; Maximillian A Rogers; Sumiko Abe-Dohmae; Toyoshi Fujimoto; Catherine C Y Chang; Masato Ishigami; Takuma Kishimoto; Toshihide Kobayashi; Kazumitsu Ueda; Koichi Furukawa; Ta-Yuan Chang; Shinji Yokoyama
Journal:  J Biol Chem       Date:  2015-07-20       Impact factor: 5.157

7.  Diacylglycerol kinase delta promotes lipogenesis.

Authors:  Yulia V Shulga; Dessi Loukov; Pavlina T Ivanova; Stephen B Milne; David S Myers; Grant M Hatch; G Umeh; Divyanshi Jalan; Morgan D Fullerton; Gregory R Steinberg; Matthew K Topham; H Alex Brown; Richard M Epand
Journal:  Biochemistry       Date:  2013-10-23       Impact factor: 3.162

Review 8.  The interplay between cell signalling and the mevalonate pathway in cancer.

Authors:  Peter J Mullen; Rosemary Yu; Joseph Longo; Michael C Archer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2016-08-26       Impact factor: 60.716

Review 9.  Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism.

Authors:  Paolo E Porporato; Valéry L Payen; Bjorn Baselet; Pierre Sonveaux
Journal:  Cell Mol Life Sci       Date:  2015-12-08       Impact factor: 9.261

10.  Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis.

Authors:  Lei Huang; Jehnan Liu; Xiao-Ou Zhang; Katelyn Sibley; Sonia M Najjar; Mary M Lee; Qiong Wu
Journal:  J Biol Chem       Date:  2018-05-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.